. Mean cost and health outcomes for weakly-dominated treatment plans in worst-case. Abbreviations: ICER: incremental cost-effectiveness ratio, QALY: quality adjusted life-year. Note that the cells with an ICER less than $50K are light shaded and those with an ICER in between $50K and $100K are dark shaded. Figure S1 . Tornado diagram representation of the sensitivity of ICER when LV5FU (the least costly efficient treatment plan in base-case) is compared with FOLFOX-LV5FU (the second least costly efficient treatment plan in base-case). Base-case ICER: $26.3K/QALY. Abbreviations: ICER: incremental cost-effectiveness ratio; QALYs: quality-adjusted life years; LV5FU : 5-fluorouracil and leucovorin; FOLFIRI : 5-fluorouracil, leucovorin, and irinotecan; FOLFOX : 5-fluorouracil, leucovorin, and oxaliplatin; CAPOX : capecitabine and oxaliplatin; bev. : bevacizumab.
